Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.42M Buy
+475,804
New +$6.55M 0.08% 96

Other funds holding IMUX

OrbiMed's IMUX Position: Q3 2026 in Review

OrbiMed opened a new position in Immunic (IMUX) in Q3 2026: 475,804 shares worth $4.42M. The stake represents 0.08% of the portfolio and ranks #96 among its holdings.

77 funds tracked by Wall St. Rank hold IMUX as of Q3 2026.

  • OrbiMed held 475,804 shares of Immunic worth $4.42M as of Q3 2026.
  • Immunic was a new OrbiMed position in Q3 2026.
  • Immunic made up 0.08% of OrbiMed's portfolio in Q3 2026, its #96 holding.
  • 77 funds tracked by Wall St. Rank held Immunic as of Q3 2026.

Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.